SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-003222
Filing Date
2020-01-13
Accepted
2020-01-13 07:30:40
Documents
3
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm202190d1_8k.htm 8-K 20112
2 EXHIBIT 99.1 tm202190d1_ex99-1.htm EX-99.1 1953
3 GRAPHIC tm202190d1_ex99-1img001.jpg GRAPHIC 74093
  Complete submission text file 0001104659-20-003222.txt   125457
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 20522779
SIC: 2834 Pharmaceutical Preparations